A detailed history of Byrne Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Byrne Asset Management LLC holds 1,494 shares of BMY stock, worth $85,651. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,494
Previous 1,728 13.54%
Holding current value
$85,651
Previous $93,000 33.33%
% of portfolio
0.05%
Previous 0.08%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$40.25 - $52.99 $9,418 - $12,399
-234 Reduced 13.54%
1,494 $62,000
Q1 2024

Apr 22, 2024

SELL
$47.98 - $54.4 $19,911 - $22,576
-415 Reduced 19.37%
1,728 $93,000
Q4 2023

Jan 29, 2024

SELL
$48.48 - $57.85 $45,425 - $54,205
-937 Reduced 30.42%
2,143 $109,000
Q3 2023

Oct 31, 2023

SELL
$57.89 - $64.73 $1,736 - $1,941
-30 Reduced 0.96%
3,080 $178,000
Q2 2023

Jul 21, 2023

SELL
$63.71 - $70.74 $5,415 - $6,012
-85 Reduced 2.66%
3,110 $198,000
Q1 2023

Apr 17, 2023

SELL
$65.71 - $74.53 $65,710 - $74,530
-1,000 Reduced 23.84%
3,195 $221,000
Q4 2022

Jan 30, 2023

SELL
$68.48 - $81.09 $78,341 - $92,766
-1,144 Reduced 21.43%
4,195 $301,000
Q3 2022

Oct 19, 2022

SELL
$0.13 - $76.84 $27 - $16,136
-210 Reduced 3.78%
5,339 $380,000
Q2 2022

Jul 20, 2022

BUY
$72.62 - $79.98 $304,858 - $335,756
4,198 Added 310.73%
5,549 $427,000
Q1 2022

Apr 05, 2022

SELL
$61.48 - $73.72 $4,488 - $5,381
-73 Reduced 5.13%
1,351 $99,000
Q4 2021

Feb 22, 2022

BUY
$53.63 - $62.52 $76,369 - $89,028
1,424 New
1,424 $89,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Byrne Asset Management LLC Portfolio

Follow Byrne Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Byrne Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Byrne Asset Management LLC with notifications on news.